Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

ChromaDex Corporation - Common Stock (NQ: CDXC )

7.830 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 12, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 50
Open 7.830
Bid (Size) 7.650 (1)
Ask (Size) 8.000 (5)
Prev. Close 7.830
Today's Range 7.830 - 7.830
52wk Range 1.770 - 9.180
Shares Outstanding 68,196,526
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
ChromaDex to Present at the 37th Annual Roth Conference
From ChromaDex Corporation
Via Business Wire
Unusual volume stocks are being observed in Thursday's session.
Which stocks have an unusual volume on Thursday? 
Via Chartmill

Performance

YTD
+42.88%
+42.88%
1 Month
+39.82%
+39.82%
3 Month
+21.40%
+21.40%
6 Month
+135.84%
+135.84%
1 Year
+301.54%
+301.54%

More News

Read More
Here are the top movers in Wednesday's session.
Via Chartmill
Insights into ChromaDex's Upcoming Earnings
Via Benzinga
Which stocks are experiencing notable movement on Wednesday?
Via Chartmill
Wednesday's session: gap up and gap down stocks
Via Chartmill
ChromaDex Corporation Reports Fourth Quarter and Fiscal Year 2024 Results
From ChromaDex Corporation
Via Business Wire
Earnings Scheduled For March 4, 2025
Via Benzinga
ChromaDex to Report Fourth Quarter and Fiscal Year 2024 Financial Results on Tuesday, March 4, 2025
From ChromaDex Corporation
Via Business Wire
ChromaDex to Participate in the Lytham Partners 2025 Investor Healthcare Summit on January 13, 2025
From ChromaDex Corporation
Via Business Wire
ChromaDex Named to the Inc. 2024 Best in Business List in the Health Products Category
From ChromaDex Corporation
Via Business Wire
Cassava Sciences, Biohaven And Other Big Stocks Moving Lower In Monday's Pre-Market Session
Via Benzinga
Why Uxin Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
Via Benzinga
ChromaDex’s Patented Nicotinamide Riboside (NR) Ingredient, Niagen®, Featured as the Hero Ingredient in Longevity.Technology’s Inaugural Longevity Supplement
From ChromaDex Corporation
Via Business Wire
ChromaDex's Pharmaceutical-Grade Niagen® IV Now Accessible at over 200 Restore Hyper Wellness Clinics Nationwide
From ChromaDex Corporation
Via Business Wire
What You Missed On Wall Street This Past Friday
Via Talk Markets
Crude Oil Moves Higher; Apple Shares Slide After Q4 Results
Via Benzinga
Exposures Fossil Fuels
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Nasdaq Surges Over 200 Points; Amazon Shares Jump After Strong Results
Via Benzinga
Dow Jumps 400 Points; US Adds 12,000 Jobs In October
Via Benzinga
Topics Stocks
Exposures US Equities
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
ChromaDex Corporation Reports Third Quarter 2024 Financial Results
From ChromaDex Corporation
Via Business Wire
ChromaDex to Report Third Quarter 2024 Financial Results on Thursday, October 31, 2024
From ChromaDex Corporation
Via Business Wire
ChromaDex to Report Third Quarter 2024 Financial Results on Thursday, October 31, 2024
From ChromaDex Corporation
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.